Article(id=1329869856855405018, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329869784935674462, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2023.03.005, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1653408000000, receivedDateStr=2022-05-25, revisedDate=1658160000000, revisedDateStr=2022-07-19, acceptedDate=null, acceptedDateStr=null, onlineDate=1794995281660, onlineDateStr=2026-11-18, pubDate=1678377600000, pubDateStr=2023-03-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794995281660, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794995281660, creator=13701087609, updateTime=1794995281660, updator=13701087609, issue=Issue{id=1329869784935674462, tenantId=1146029695717560320, journalId=1319690329412173987, year='2023', volume='44', issue='3', pageStart='197', pageEnd='297', issueExtLink='null', onlineDate='null', pubDate='1678377600000', pubDateStr='2023-03-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794995264514, creator='13701087609', updateTime=1794995823118, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329872128242987421, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329869784935674462, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329872128242987422, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329869784935674462, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=220, endPage=228, ext={EN=ArticleExt(id=1329869857174172123, articleId=1329869856855405018, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Study on the inhibitory effects of afatinib on proliferation, migration and invasion of pancreatic carcinoma cells, columnId=1325221089055486019, journalTitle=World Clinical Drug, columnName=Article, runingTitle=null, highlight=null, articleAbstract=
Objective

To investigate the anticancer effects and potential mechanism of afatinib in pancreatic carcinoma (PC).

Methods

Capan-1 cells were treated with 0.5, 1.0, 2.0 and 4.0 μmol/L afatinib for 24 h, and normal cultured cells were set as control group. Capan-1 cells were transfected with maternally expressed gene (MEG)3 overexpressed plasmid (pcDNA-MEG3) and empty loaded plasmid (pcDNA) for 48 h, respectively, which were set as pcDNA-MEG3 group and pcDNA group. Capan-1 cells transfected with MEG3 small interfering RNA (si-MEG3) were treated with 4.0 μmol/L afatinib for 24 h as 4.0 μmol/L afatinib+si-MEG3 group and 4.0 μmol/L afatinib+negative control (NC) group. Flow cytometry was used to detect cell cycle distribution. Transwell assay was used to detect cell migration and invasion. Quantitative reverse transcriptase-mediated polymerase chain reaction (qRT-PCR) was used to measure the expression of MEG3. The expressions of Cyclin D1, matrix metalloproteinase (MMP)2 and MMP9 were determined by western blotting.

Results

Compared with the control group, Cyclin D1 protein expression, S phase cell proportion, migration and invasion number of Capan-1 cells, MMP2 and MMP9 protein expression decreased, G0/G1 phase cell proportion increased, MEG3 expression level of Capan-1 cells increased in afatinib group. The differences were statistically significant (P<0.05). Compared with human pancreatic ductal epithelial cells, MEG3 expression level in Capan-1 cells was decreased (P<0.05). Compared with the pcDNA group, MEG3 expression and the proportion of G0/G1 phase cells in Capan-1 cells in pcDNA-MEG3 group were increased, while the proportion of S phase cells, the number of cell migration and invasion, and the expression of Cyclin D1, MMP2 and MMP9 protein were decreased, with statistical significance (P<0.05). Compared with 4.0 μmol/L Afatinib+si-NC group, MEG3 expression and G0/G1 phase of Capan-1 cells in 4.0 μmol/L afatinib+si-MEG3 group were significantly decreased. The proportion of cells in S phase, the number of cell migration and invasion, and the protein expressions of Cyclin D1, MMP2 and MMP9 were significantly increased, with statistical significance (P<0.05).

Conclusion

Afatinib can inhibit Capan-1 proliferation, migration and invasion of pancreatic cancer cells by up-regulating MEG3 expression.

, authors=Ruitong ZHANG1, Zhen LI2, *, authorsList=Ruitong ZHANG, Zhen LI, authorCompany=null, correspAuthors=Zhen LI, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329869857413247452, articleId=1329869856855405018, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=阿法替尼抑制胰腺癌细胞的增殖、迁移和侵袭研究, columnId=1325221089235841093, journalTitle=世界临床药物, columnName=研究论文, runingTitle=null, highlight=null, articleAbstract=
目的

探讨阿法替尼在胰腺癌(pancreatic carcinoma,PC)中的抗肿瘤作用和潜在机制。

方法

分别用0.5、1.0、2.0及4.0 μmol/L阿法替尼干预PC细胞Capan-1细胞24 h,并将正常培养细胞作为对照组,另取Capan-1细胞分别转染母系表达基因(maternally expressed gene,MEG)3过表达质粒(pcDNA-MEG3)和空载质粒(pcDNA)48 h后,记为pcDNA-MEG3组、pcDNA组,Capan-1细胞转染MEG3小干扰RNA(si-MEG3)后用含4.0 μmol/L阿法替尼干预24 h记为4.0 μmol/L阿法替尼+si-MEG3组和4.0 μmol/L阿法替尼+si-空白对照(negative control,NC)组。采用流式细胞术检测细胞周期分布情况;Transwell实验检测细胞迁移侵袭情况;定量反转录聚合酶链反应(quantitative reverse transcriptase-mediated polymerase chain reaction,qRT-PCR)检测细胞MEG3表达的情况;采用免疫印记法检测细胞周期蛋白D1(Cyclin D1)、基质金属蛋白酶(matrix metalloproteinase,MMP)2和MMP9蛋白表达。

结果

与对照组比较,各剂量阿法替尼组Capan-1细胞Cyclin D1蛋白表达、S期细胞比例减少,Capan-1细胞迁移和侵袭数量、MMP2和MMP9蛋白表达降低,G0/G1期细胞比例增多,Capan-1细胞MEG3表达水平升高,差异均有统计学意义(P<0.05)。与人胰腺导管上皮细胞比较,Capan-1细胞中MEG3表达水平降低(P<0.05)。与pcDNA组比较,pcDNA-MEG3组Capan-1细胞MEG3表达、G0/G1期细胞比例升高,S期细胞比例、细胞迁移和侵袭数量及Cyclin D1、MMP2、MMP9蛋白表达降低,差异均有统计学意义(P<0.05)。与4.0 μmol/L阿法替尼+si-NC组比较,4.0 μmol/L阿法替尼+si-MEG3组Capan-1细胞MEG3表达、G0/G1期细胞比例显著降低,S期细胞比例、细胞迁移和侵袭数量及Cyclin D1、MMP2、MMP9蛋白表达显著升高,差异均有统计学意义(P<0.05)。

结论

阿法替尼通过上调MEG3表达可抑制PC细胞Capan-1增殖、迁移和侵袭。

, authors=张瑞桐1, 李震2, *, authorsList=张瑞桐, 李震, authorCompany=null, correspAuthors=李震, authorNote=

张瑞桐,主管药师,研究方向:肿瘤药物临床试验研究。

, correspAuthorsNote=
李震,主任药师,研究方向:创新药临床研究。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=vSrcpKb4NYlO3Ps2TThKCw==, magXml=yHTEsDXw2FyVqbK8pk82+g==, pdfUrl=null, pdf=9VqJOW/9sR1hGhDg+AtKog==, pdfFileSize=7146528, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=sZyrzOgiTxOhLK2DUAe0JQ==, mapNumber=null, fund=null)}, authors=[Author(id=1329869857769763302, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329869857857843689, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, authorId=1329869857769763302, language=EN, stringName=Ruitong ZHANG, firstName=Ruitong, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Pharmacy, Nanyang Central Hospital, Nanyang 473005, Henan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329869857920758250, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, authorId=1329869857769763302, language=CN, stringName=张瑞桐, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.河南省南阳市中心医院药剂科,河南 南阳 473005, bio={"content":"

张瑞桐,主管药师,研究方向:肿瘤药物临床试验研究。

"}, bioImg=null, bioContent=

张瑞桐,主管药师,研究方向:肿瘤药物临床试验研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329869857597796831, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, xref=1., ext=[AuthorCompanyExt(id=1329869857601991136, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, companyId=1329869857597796831, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Nanyang Central Hospital, Nanyang 473005, Henan Province, China), AuthorCompanyExt(id=1329869857610379745, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, companyId=1329869857597796831, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.河南省南阳市中心医院药剂科,河南 南阳 473005)])]), Author(id=1329869857987867116, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329869858059170286, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, authorId=1329869857987867116, language=EN, stringName=Zhen LI, firstName=Zhen, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Static Distribution Center, Nanyang Central Hospital, Nanyang 473005, Henan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329869858138862063, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, authorId=1329869857987867116, language=CN, stringName=李震, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.河南省南阳市中心医院静配中心,河南 南阳 473005, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329869857685877218, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, xref=2., ext=[AuthorCompanyExt(id=1329869857694265827, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, companyId=1329869857685877218, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Static Distribution Center, Nanyang Central Hospital, Nanyang 473005, Henan Province, China), AuthorCompanyExt(id=1329869857698460132, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, companyId=1329869857685877218, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.河南省南阳市中心医院静配中心,河南 南阳 473005)])])], keywords=[Keyword(id=1329869858231136752, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, language=EN, orderNo=1, keyword=afatinib), Keyword(id=1329869858294051313, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, language=EN, orderNo=2, keyword=pancreatic cancer), Keyword(id=1329869858398908914, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, language=EN, orderNo=3, keyword=migration), Keyword(id=1329869858470212083, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, language=EN, orderNo=4, keyword=invasion), Keyword(id=1329869858549903860, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, language=EN, orderNo=5, keyword=long non-coding RNA maternally expressed gene 3), Keyword(id=1329869858621207029, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, language=EN, orderNo=6, keyword=cell cycle), Keyword(id=1329869858705093110, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, language=CN, orderNo=1, keyword=阿法替尼), Keyword(id=1329869858772201975, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, language=CN, orderNo=2, keyword=胰腺癌), Keyword(id=1329869858851893754, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, language=CN, orderNo=3, keyword=迁移), Keyword(id=1329869858956751355, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, language=CN, orderNo=4, keyword=侵袭), Keyword(id=1329869859028054524, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, language=CN, orderNo=5, keyword=长链非编码RNA母系表达基因3), Keyword(id=1329869859128717821, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, language=CN, orderNo=6, keyword=细胞周期)], refs=[Reference(id=1329869859334238720, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Specenier P, Vermorken J. Afatinib in squamous cell carcinoma of the head and neck[J]. Expert Opin Pharmacother, 2016, 17(9): 1295-1301., articleTitle=null, refAbstract=null), Reference(id=1329869859409736193, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Harbeck N, Solca F, Gauler TC. Preclinical and clinical development of afatinib: a focus on breast cancer and squamous cell carcinoma of the head and neck[J]. Future Oncol, 2014, 10(1): 21-40., articleTitle=null, refAbstract=null), Reference(id=1329869859485233666, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=封雪, 赵滨滨, 王咏强. 布比卡因调控LncRNA LBX2-AS1对宫颈癌细胞SiHa增殖及凋亡的影响[J]. 中国药师, 2021, 24(10): 1829-1832., articleTitle=null, refAbstract=null), Reference(id=1329869859581702659, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Dai Y, Wan Y, Qiu M, et al. lncRNA MEG3 suppresses the tumorigenesis of hemangioma by sponging miR-494 and regulating PTEN/PI3K/AKT pathway[J]. Cell Physiol Biochem, 2018, 51(6): 2872-2886., articleTitle=null, refAbstract=null), Reference(id=1329869859653005828, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Wang C, Yan G, Zhang Y, et al. Long non-coding RNA MEG3 suppresses migration and invasion of thyroid carcinoma by targeting of Rac1[J]. Neoplasma, 2015, 62(4): 541-549., articleTitle=null, refAbstract=null), Reference(id=1329869859732697605, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Gu L, Zhang J, Shi M, et al. lncRNA MEG3 had anti-cancer effects to suppress pancreatic cancer activity[J]. Biomed Pharmacother, 2017, 89: 1269-1276., articleTitle=null, refAbstract=null), Reference(id=1329869859812389382, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Ma L, Wang F, Du C, et al. Long non-coding RNA MEG3 functions as a tumour suppressor and has prognostic predictive value in human pancreatic cancer[J]. Oncol Rep, 2018, 39(3): 1132-1140., articleTitle=null, refAbstract=null), Reference(id=1329869860001133063, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=王胜奇, 宋志华, 梁倩莹, 等. 阿法替尼对人卵巢癌细胞的增殖抑制作用及其机制研究[J]. 今日药学, 2016, 26(9): 630-632., articleTitle=null, refAbstract=null), Reference(id=1329869860072436232, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Tang Y, Zhang X, Qi F, et al. Afatinib inhibits proliferation and invasion and promotes apoptosis of the T24 bladder cancer cell line[J]. Exp Ther Med, 2015, 9(5): 1851-1856., articleTitle=null, refAbstract=null), Reference(id=1329869860139545097, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=赵颖, 迟江瑞, 赵洪猛, 等. 阿法替尼对人乳腺癌细胞增殖与凋亡的影响及机制研究[J]. 中国肿瘤临床, 2017, 44(15): 739-743., articleTitle=null, refAbstract=null), Reference(id=1329869860244402698, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Ding J, Xu K, Sun S, et al. SOCS1 blocks G1-S transition in hepatocellular carcinoma by reducing the stability of the CyclinD1/CDK4 complex in the nucleus[J]. Aging (Albany NY), 2020, 12(4): 3962-3975., articleTitle=null, refAbstract=null), Reference(id=1329869860361843211, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Zong L, Li J, Chen X, et al. Lipoxin A4 attenuates cell invasion by inhibiting ROS/ERK/MMP pathway in pancreatic cancer[J]. Oxid Med Cell Longev, 2016, 2016: 6815727., articleTitle=null, refAbstract=null), Reference(id=1329869860449923597, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=袁茵, 宫颢, 李永文, 等. 阿帕替尼对肺癌细胞侵袭迁移的影响及其作用机制[J]. 中国肺癌杂志, 2019, 22(5): 264-270., articleTitle=null, refAbstract=null), Reference(id=1329869860542198287, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Wei GH, Wang X. lncRNA MEG3 inhibit proliferation and metastasis of gastric cancer via p53 signaling pathway[J]. Eur Rev Med Pharmacol Sci, 2017, 21(17): 3850-3856., articleTitle=null, refAbstract=null), Reference(id=1329869860609307152, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Yang Z, Wang Z, Duan Y. lncRNA MEG3 inhibits non-small cell lung cancer via interaction with DKC1 protein[J]. Oncol Lett, 2020, 20(3): 2183-2190., articleTitle=null, refAbstract=null), Reference(id=1329869860688998929, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Wang W, Xie Y, Chen F, et al. LncRNA MEG3 acts a biomarker and regulates cell functions by targeting ADAR1 in colorectal cancer[J]. World J Gastroenterol, 2019, 25(29): 3972-3984., articleTitle=null, refAbstract=null), Reference(id=1329869860781273618, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhang X, Wu N, Wang J, et al. lncRNA MEG3 inhibits cell proliferation and induces apoptosis in laryngeal cancer via miR-23a/APAF-1 axis[J]. J Cell Mol Med, 2019, 23(10): 6708-6719., articleTitle=null, refAbstract=null), Reference(id=1329869860865159700, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Gong X, Huang MY. Tumor-Suppressive function of lncRNA-MEG3 in glioma cells by regulating miR-6088/SMARCB1 axis[J]. Biomed Res Int, 2020, 2020: 4309161., articleTitle=null, refAbstract=null), Reference(id=1329869860940657173, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Hu D, Su C, Jiang M, et al. Fenofibrate inhibited pancreatic cancer cells proliferation via activation of p53 mediated by upregulation of lncRNA MEG3[J]. Biochem Biophys Res Commun, 2016, 471(2): 290-295., articleTitle=null, refAbstract=null)], funds=[Fund(id=1329869859233575424, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, awardId=192102310326, language=CN, fundingSource=南阳市科技攻关项目(192102310326), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1329869857597796831, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, xref=1., ext=[AuthorCompanyExt(id=1329869857601991136, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, companyId=1329869857597796831, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Nanyang Central Hospital, Nanyang 473005, Henan Province, China), AuthorCompanyExt(id=1329869857610379745, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, companyId=1329869857597796831, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.河南省南阳市中心医院药剂科,河南 南阳 473005)]), AuthorCompany(id=1329869857685877218, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, xref=2., ext=[AuthorCompanyExt(id=1329869857694265827, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, companyId=1329869857685877218, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Static Distribution Center, Nanyang Central Hospital, Nanyang 473005, Henan Province, China), AuthorCompanyExt(id=1329869857698460132, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, companyId=1329869857685877218, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.河南省南阳市中心医院静配中心,河南 南阳 473005)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2023.03.005, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2023.03.005, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2023.03.005, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2023.03.005, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1678377600000, fullTextJson=null, articleText=null, reference=null)
收藏切换
阿法替尼抑制胰腺癌细胞的增殖、迁移和侵袭研究
张瑞桐 1 , 李震 2, *
世界临床药物 | 研究论文 2023,44(3): 220-228
收起
收藏切换
世界临床药物 |研究论文 2023 , 44 (3) : 220 -228
阿法替尼抑制胰腺癌细胞的增殖、迁移和侵袭研究
全屏
[Author(id=1329869857769763302, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329869857857843689, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, authorId=1329869857769763302, language=EN, stringName=Ruitong ZHANG, firstName=Ruitong, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Pharmacy, Nanyang Central Hospital, Nanyang 473005, Henan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329869857920758250, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, authorId=1329869857769763302, language=CN, stringName=张瑞桐, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.河南省南阳市中心医院药剂科,河南 南阳 473005, bio={"content":"

张瑞桐,主管药师,研究方向:肿瘤药物临床试验研究。

"}, bioImg=null, bioContent=

张瑞桐,主管药师,研究方向:肿瘤药物临床试验研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329869857597796831, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, xref=1., ext=[AuthorCompanyExt(id=1329869857601991136, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, companyId=1329869857597796831, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Nanyang Central Hospital, Nanyang 473005, Henan Province, China), AuthorCompanyExt(id=1329869857610379745, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, companyId=1329869857597796831, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.河南省南阳市中心医院药剂科,河南 南阳 473005)])]), Author(id=1329869857987867116, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329869858059170286, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, authorId=1329869857987867116, language=EN, stringName=Zhen LI, firstName=Zhen, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Static Distribution Center, Nanyang Central Hospital, Nanyang 473005, Henan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329869858138862063, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, authorId=1329869857987867116, language=CN, stringName=李震, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.河南省南阳市中心医院静配中心,河南 南阳 473005, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329869857685877218, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, xref=2., ext=[AuthorCompanyExt(id=1329869857694265827, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, companyId=1329869857685877218, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Static Distribution Center, Nanyang Central Hospital, Nanyang 473005, Henan Province, China), AuthorCompanyExt(id=1329869857698460132, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869856855405018, companyId=1329869857685877218, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.河南省南阳市中心医院静配中心,河南 南阳 473005)])])]
张瑞桐1, 李震2, *
作者信息
  • 1.河南省南阳市中心医院药剂科,河南 南阳 473005
  • 2.河南省南阳市中心医院静配中心,河南 南阳 473005
通讯作者:
李震,主任药师,研究方向:创新药临床研究。
作者简介:

张瑞桐,主管药师,研究方向:肿瘤药物临床试验研究。

Study on the inhibitory effects of afatinib on proliferation, migration and invasion of pancreatic carcinoma cells
Ruitong ZHANG1, Zhen LI2, *
Affiliations
  • 1.Department of Pharmacy, Nanyang Central Hospital, Nanyang 473005, Henan Province, China
  • 2.Static Distribution Center, Nanyang Central Hospital, Nanyang 473005, Henan Province, China
出版时间: 2023-03-10 doi: 10.13683/j.wph.2023.03.005
文章导航
收藏切换
目的

探讨阿法替尼在胰腺癌(pancreatic carcinoma,PC)中的抗肿瘤作用和潜在机制。

方法

分别用0.5、1.0、2.0及4.0 μmol/L阿法替尼干预PC细胞Capan-1细胞24 h,并将正常培养细胞作为对照组,另取Capan-1细胞分别转染母系表达基因(maternally expressed gene,MEG)3过表达质粒(pcDNA-MEG3)和空载质粒(pcDNA)48 h后,记为pcDNA-MEG3组、pcDNA组,Capan-1细胞转染MEG3小干扰RNA(si-MEG3)后用含4.0 μmol/L阿法替尼干预24 h记为4.0 μmol/L阿法替尼+si-MEG3组和4.0 μmol/L阿法替尼+si-空白对照(negative control,NC)组。采用流式细胞术检测细胞周期分布情况;Transwell实验检测细胞迁移侵袭情况;定量反转录聚合酶链反应(quantitative reverse transcriptase-mediated polymerase chain reaction,qRT-PCR)检测细胞MEG3表达的情况;采用免疫印记法检测细胞周期蛋白D1(Cyclin D1)、基质金属蛋白酶(matrix metalloproteinase,MMP)2和MMP9蛋白表达。

结果

与对照组比较,各剂量阿法替尼组Capan-1细胞Cyclin D1蛋白表达、S期细胞比例减少,Capan-1细胞迁移和侵袭数量、MMP2和MMP9蛋白表达降低,G0/G1期细胞比例增多,Capan-1细胞MEG3表达水平升高,差异均有统计学意义(P<0.05)。与人胰腺导管上皮细胞比较,Capan-1细胞中MEG3表达水平降低(P<0.05)。与pcDNA组比较,pcDNA-MEG3组Capan-1细胞MEG3表达、G0/G1期细胞比例升高,S期细胞比例、细胞迁移和侵袭数量及Cyclin D1、MMP2、MMP9蛋白表达降低,差异均有统计学意义(P<0.05)。与4.0 μmol/L阿法替尼+si-NC组比较,4.0 μmol/L阿法替尼+si-MEG3组Capan-1细胞MEG3表达、G0/G1期细胞比例显著降低,S期细胞比例、细胞迁移和侵袭数量及Cyclin D1、MMP2、MMP9蛋白表达显著升高,差异均有统计学意义(P<0.05)。

结论

阿法替尼通过上调MEG3表达可抑制PC细胞Capan-1增殖、迁移和侵袭。

阿法替尼  /  胰腺癌  /  迁移  /  侵袭  /  长链非编码RNA母系表达基因3  /  细胞周期
Objective

To investigate the anticancer effects and potential mechanism of afatinib in pancreatic carcinoma (PC).

Methods

Capan-1 cells were treated with 0.5, 1.0, 2.0 and 4.0 μmol/L afatinib for 24 h, and normal cultured cells were set as control group. Capan-1 cells were transfected with maternally expressed gene (MEG)3 overexpressed plasmid (pcDNA-MEG3) and empty loaded plasmid (pcDNA) for 48 h, respectively, which were set as pcDNA-MEG3 group and pcDNA group. Capan-1 cells transfected with MEG3 small interfering RNA (si-MEG3) were treated with 4.0 μmol/L afatinib for 24 h as 4.0 μmol/L afatinib+si-MEG3 group and 4.0 μmol/L afatinib+negative control (NC) group. Flow cytometry was used to detect cell cycle distribution. Transwell assay was used to detect cell migration and invasion. Quantitative reverse transcriptase-mediated polymerase chain reaction (qRT-PCR) was used to measure the expression of MEG3. The expressions of Cyclin D1, matrix metalloproteinase (MMP)2 and MMP9 were determined by western blotting.

Results

Compared with the control group, Cyclin D1 protein expression, S phase cell proportion, migration and invasion number of Capan-1 cells, MMP2 and MMP9 protein expression decreased, G0/G1 phase cell proportion increased, MEG3 expression level of Capan-1 cells increased in afatinib group. The differences were statistically significant (P<0.05). Compared with human pancreatic ductal epithelial cells, MEG3 expression level in Capan-1 cells was decreased (P<0.05). Compared with the pcDNA group, MEG3 expression and the proportion of G0/G1 phase cells in Capan-1 cells in pcDNA-MEG3 group were increased, while the proportion of S phase cells, the number of cell migration and invasion, and the expression of Cyclin D1, MMP2 and MMP9 protein were decreased, with statistical significance (P<0.05). Compared with 4.0 μmol/L Afatinib+si-NC group, MEG3 expression and G0/G1 phase of Capan-1 cells in 4.0 μmol/L afatinib+si-MEG3 group were significantly decreased. The proportion of cells in S phase, the number of cell migration and invasion, and the protein expressions of Cyclin D1, MMP2 and MMP9 were significantly increased, with statistical significance (P<0.05).

Conclusion

Afatinib can inhibit Capan-1 proliferation, migration and invasion of pancreatic cancer cells by up-regulating MEG3 expression.

afatinib  /  pancreatic cancer  /  migration  /  invasion  /  long non-coding RNA maternally expressed gene 3  /  cell cycle
张瑞桐, 李震. 阿法替尼抑制胰腺癌细胞的增殖、迁移和侵袭研究. 世界临床药物, 2023 , 44 (3) : 220 -228 . DOI: 10.13683/j.wph.2023.03.005
Ruitong ZHANG, Zhen LI. Study on the inhibitory effects of afatinib on proliferation, migration and invasion of pancreatic carcinoma cells[J]. World Clinical Drug, 2023 , 44 (3) : 220 -228 . DOI: 10.13683/j.wph.2023.03.005
  • 南阳市科技攻关项目(192102310326)
参考文献 引证文献
排序方式:
[1]
Specenier P, Vermorken J. Afatinib in squamous cell carcinoma of the head and neck[J]. Expert Opin Pharmacother, 2016, 17(9): 1295-1301.
[2]
Harbeck N, Solca F, Gauler TC. Preclinical and clinical development of afatinib: a focus on breast cancer and squamous cell carcinoma of the head and neck[J]. Future Oncol, 2014, 10(1): 21-40.
[3]
封雪, 赵滨滨, 王咏强. 布比卡因调控LncRNA LBX2-AS1对宫颈癌细胞SiHa增殖及凋亡的影响[J]. 中国药师, 2021, 24(10): 1829-1832.
[4]
Dai Y, Wan Y, Qiu M, et al. lncRNA MEG3 suppresses the tumorigenesis of hemangioma by sponging miR-494 and regulating PTEN/PI3K/AKT pathway[J]. Cell Physiol Biochem, 2018, 51(6): 2872-2886.
[5]
Wang C, Yan G, Zhang Y, et al. Long non-coding RNA MEG3 suppresses migration and invasion of thyroid carcinoma by targeting of Rac1[J]. Neoplasma, 2015, 62(4): 541-549.
[6]
Gu L, Zhang J, Shi M, et al. lncRNA MEG3 had anti-cancer effects to suppress pancreatic cancer activity[J]. Biomed Pharmacother, 2017, 89: 1269-1276.
[7]
Ma L, Wang F, Du C, et al. Long non-coding RNA MEG3 functions as a tumour suppressor and has prognostic predictive value in human pancreatic cancer[J]. Oncol Rep, 2018, 39(3): 1132-1140.
[8]
王胜奇, 宋志华, 梁倩莹, 等. 阿法替尼对人卵巢癌细胞的增殖抑制作用及其机制研究[J]. 今日药学, 2016, 26(9): 630-632.
[9]
Tang Y, Zhang X, Qi F, et al. Afatinib inhibits proliferation and invasion and promotes apoptosis of the T24 bladder cancer cell line[J]. Exp Ther Med, 2015, 9(5): 1851-1856.
[10]
赵颖, 迟江瑞, 赵洪猛, 等. 阿法替尼对人乳腺癌细胞增殖与凋亡的影响及机制研究[J]. 中国肿瘤临床, 2017, 44(15): 739-743.
[11]
Ding J, Xu K, Sun S, et al. SOCS1 blocks G1-S transition in hepatocellular carcinoma by reducing the stability of the CyclinD1/CDK4 complex in the nucleus[J]. Aging (Albany NY), 2020, 12(4): 3962-3975.
[12]
Zong L, Li J, Chen X, et al. Lipoxin A4 attenuates cell invasion by inhibiting ROS/ERK/MMP pathway in pancreatic cancer[J]. Oxid Med Cell Longev, 2016, 2016: 6815727.
[13]
袁茵, 宫颢, 李永文, 等. 阿帕替尼对肺癌细胞侵袭迁移的影响及其作用机制[J]. 中国肺癌杂志, 2019, 22(5): 264-270.
[14]
Wei GH, Wang X. lncRNA MEG3 inhibit proliferation and metastasis of gastric cancer via p53 signaling pathway[J]. Eur Rev Med Pharmacol Sci, 2017, 21(17): 3850-3856.
[15]
Yang Z, Wang Z, Duan Y. lncRNA MEG3 inhibits non-small cell lung cancer via interaction with DKC1 protein[J]. Oncol Lett, 2020, 20(3): 2183-2190.
[16]
Wang W, Xie Y, Chen F, et al. LncRNA MEG3 acts a biomarker and regulates cell functions by targeting ADAR1 in colorectal cancer[J]. World J Gastroenterol, 2019, 25(29): 3972-3984.
[17]
Zhang X, Wu N, Wang J, et al. lncRNA MEG3 inhibits cell proliferation and induces apoptosis in laryngeal cancer via miR-23a/APAF-1 axis[J]. J Cell Mol Med, 2019, 23(10): 6708-6719.
[18]
Gong X, Huang MY. Tumor-Suppressive function of lncRNA-MEG3 in glioma cells by regulating miR-6088/SMARCB1 axis[J]. Biomed Res Int, 2020, 2020: 4309161.
[19]
Hu D, Su C, Jiang M, et al. Fenofibrate inhibited pancreatic cancer cells proliferation via activation of p53 mediated by upregulation of lncRNA MEG3[J]. Biochem Biophys Res Commun, 2016, 471(2): 290-295.
2023年第44卷第3期
10
2
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2023.03.005
  • 接收时间:2022-05-25
  • 首发时间:2026-11-18
  • 出版时间:2023-03-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2022-05-25
  • 修回日期:2022-07-19
基金
南阳市科技攻关项目(192102310326)
作者信息
    1.河南省南阳市中心医院药剂科,河南 南阳 473005
    2.河南省南阳市中心医院静配中心,河南 南阳 473005

通讯作者:

李震,主任药师,研究方向:创新药临床研究。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2023.03.005
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏